APRIL Antibodies

Santa Cruz Biotechnology features a diverse variety of APRIL Antibodies for investigating A Proliferation-Inducing Ligand (APRIL) in biological processes. Monoclonal APRIL antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). APRIL, a member of the tumor necrosis factor (TNF) superfamily, plays a critical role in regulating B cell survival and proliferation. Research has shown APRIL's involvement in immune responses and its connection to various diseases, including autoimmune disorders and cancers. Understanding APRIL's function continues to be a focus in developing targeted therapies and advancing knowledge of immune system dynamics. Monoclonal APRIL antibodies enable precise detection and characterization of APRIL expression patterns in different tissues and cell types. Researchers can track APRIL's distribution and activity across various experimental conditions using specific immunological techniques. Advanced visualization methods, including fluorescent conjugates such as phycoerythrin (PE), fluorescein isothiocyanate (FITC), and horseradish peroxidase (HRP), enhance the detection capabilities of APRIL monoclonal antibodies. Santa Cruz Biotechnology monoclonal APRIL antibodies support researchers worldwide in advancing scientific understanding of immune system regulation and disease mechanisms.